Results 71 to 80 of about 28,738 (154)
The paper deals with an update on biologically active additives (BAAs) and emphasizes their role in normalizing and/or improving the functional status of organs and systems, including the gastrointestinal tract microflora, in reducing the risk of ...
I. S. Dydykina +4 more
doaj +1 more source
Diallyl trisulfides (DATs) selectively induce cuproptosis in hepatic stellate cells (HSCs) by targeting Ras‐related protein Rab‐18 (RAB18) and regulating lipophagy. DATs promote RAB18 phase separation, enhance mitochondrial‐associated membrane structures (MAMs) formation, and increase succinylation of dihydrolipoamide dehydrogenase (DLD) at K320.
Haoyuan Tian +16 more
wiley +1 more source
This study aims to extract pepsin soluble collagen from sturgeon cartilage, hydrolyze to collagen peptides and prepare SCCP nanoliposomes to explore the treatment effects of osteoarthritis in rats. ABSTRACT This study aims to extract pepsin soluble collagen (PSC) from sturgeon cartilage, hydrolyze to sturgeon cartilage collagen peptides (SCCP), and ...
Chia‐Chi Kung +2 more
wiley +1 more source
Osteoartritis merupakan penyakit sendi yang paling sering dialami oleh manusia, terutama lutut. Osteoartritis lutut terjadi sekitar 15,5% pada pria dan 12,7% pada wanita di Indonesia.
Muhammad Yamin, D Henky Lesmana
doaj +1 more source
A Literature Review of Undenatured type II collagen (UC-II) in Joint Health and Disease
Undenatured type II collagen (UC-II) is supplementary which is from chicken sternum cartilage. (Lugo, J. P., Saiyed,…,2015) UC-II has undenatured type II collagen componentand. The safety and capability of UC-II in adjusting joint discomfort in Osteoarthritis and Rheumatoid arthritis support by previous preclinical and clinical studies. (Lugo, J.
openaire +2 more sources
Collagen from eggshell membrane (EM) was stabilized via a cross‐linking procedure using microbial transglutaminase as an alternative, nontoxic cross‐linking reagent for its low stability and low mechanical strength. The physicochemical features of collagen solutions (5 mg/mL), which were cross‐linked by different concentrations of MTG (30, 40, 50, 60 ...
Elahe Kazemi Kheirabadi +4 more
wiley +1 more source
Evidence base of pharmaconutraceuticals with chondroprotective action
Background. Osteoarthritis is one of the most common chronic diseases of the musculoskeletal system worldwide, being a common cause of chronic pain syndrome and disability.
O. A. Shavlovskaya +2 more
doaj +1 more source
In 2021, an article was published comparing two commercial products containing undenatured type II collagen: b-2Cool® (Bioiberica, S.A.U., Barcelona, Spain; designated CII-X, X1, and X2) and UC-II (Lonza Consumer Health Inc, USA; designated CII-Y, Y1, and Y2). However, we feel certain concerns remain where clarification may be warranted.
openaire +2 more sources
Current evidence for non‐pharmaceutical, non‐surgical treatments of canine osteoarthritis
Osteoarthritis is a progressive degenerative disease process that affects a significant proportion of the canine population, impacting these animals' quality of life. Currently, there is no cure and treatment consists of managing the clinical signs of pain and reduced mobility.
C. Pye +4 more
wiley +1 more source
The aim of the study was to compare the metabolomic synovial fluid (SF) profile of dogs affected by spontaneous osteoarthritis (OA) and supplemented with undenatured type II collagen (UC-II), with that of healthy control dogs.
Marzia Stabile +6 more
doaj +1 more source

